Guidance for Core Labs (CLB)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| Q4 2022 | $0.17 – $0.21 | $0.17 | $126.00M – 131.00M | $129.98M | = Maintained | Details |
| Q2 2022 | $0.12 – $0.16 | $0.13 | $119.00M – 125.00M | $114.30M | = Maintained | Details |
| Q1 2022 | $0.16 – $0.20 | $0.17 | $117.00M – 122.00M | $109.50M | = Maintained | Details |
| Q4 2021 | $0.18 – $0.22 | $0.19 | $121.00M – 124.00M | $108.00M | = Maintained | Details |
| Q3 2021 | $0.19 – $0.21 | $0.23 | N/A | N/A | = Maintained | Details |
| Q1 2020 | $0.39 – $0.41 | $0.39 | $159.00M – 164.00M | $159.40M | = Maintained | Details |
| Q4 2019 | $0.44 – $0.45 | $0.46 | $161.00M – 163.00M | $169.70M | = Maintained | Details |
| Q3 2019 | $0.48 – $0.52 | $0.51 | $171.00M – 175.00M | $179.66M | = Maintained | Details |
| Q2 2019 | $0.47 – $0.50 | $0.49 | $172.00M – 175.00M | $174.30M | = Maintained | Details |
| Q4 2018 | $0.48 – $0.54 | $0.58 | $173.00M – 176.00M | $175.80M | = Maintained | Details |
| Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | $0.48 – $0.52 | $0.48 | N/A | N/A |  Raised |
Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2016 | $0.38 – $0.40 | $0.41 | $143.00M – 145.00M | $148.20M |  Lowered |
Details |
| Q3 2016 | $0.39 – $0.41 | $0.41 | $148.00M – 151.00M | $149.40M | = Maintained | Details |
| Q4 2015 | $0.84 – $0.86 | $0.85 | $205.00M – 210.00M | $200.00M | = Maintained | Details |
| Q4 2015 | $0.63 – $0.67 | $0.75 | $180.00M | $191.94M | Lowered |
Details |
| Q3 2015 | $0.82 – $0.84 | $0.80 | $203.00M – 205.00M | $195.00M | = Maintained | Details |
| 2014 | $6.00 – $6.25 | $6.21 | $1.12B – 1.18B | $1.18B | = Maintained | Details |
| 2014 | $6.00 – $6.25 | $6.17 | $1.16B – 1.18B | $1.19B | = Maintained | Details |
| Q4 2014 | $1.56 – $1.61 | N/A | $285.00M – 295.00M | N/A | = Maintained | Details |
| Q4 2014 | $1.53 – $1.56 | $1.60 | $275.00M – 280.00M | $292.80M | = Maintained | Details |
| Q3 2014 | $1.49 – $1.52 | $1.52 | $280.00M – 290.00M | $284.60M | = Maintained | Details |
| Q2 2014 | $1.48 – $1.53 | $1.53 | $280.00M – 286.00M | $289.80M | = Maintained | Details |
| Q1 2014 | $1.43 – $1.45 | $1.43 | N/A | N/A | = Maintained | Details |
| 2013 | $5.06 – $5.26 | $5.12 | $1.06B – 1.05B | $1.06B | = Maintained | Details |
| 2013 | $4.96 – $5.22 | $4.98 | $1.02B – 1.07B | $1.05B | = Maintained | Details |
| Q4 2013 | $1.39 – $1.40 | $1.38 | $278.00M – 281.00M | $272.60M | = Maintained | Details |
| Q4 2013 | $1.37 – $1.38 | $1.38 | $268.00M – 270.00M | N/A | = Maintained | Details |
| Q3 2013 | $1.33 – $1.34 | $1.34 | $263.00M – 268.00M | $270.38M | = Maintained | Details |
| Q1 2013 | $1.12 – $1.18 | $1.12 | $240.00M – 250.00M | $242.30M | = Maintained | Details |
| 2012 | $4.50 – $4.82 | $4.67 | N/A | N/A | = Maintained | Details |
| Q4 2012 | $1.10 – $1.17 | $1.12 | $245.00M – 250.00M | $252.10M | = Maintained | Details |
| Q3 2012 | $1.17 – $1.25 | $1.24 | $250.00M – 260.00M | $263.70M | = Maintained | Details |
| Q1 2012 | $1.01 – $1.06 | $1.08 | N/A | N/A | = Maintained | Details |
| 2011 | $3.73 – $3.75 | $3.75 | $904.00M – 910.00M | $923.48M | Raised |
Details |
| 2011 | $3.55 – $3.60 | $3.69 | $910.00M – 930.00M | $906.93M | = Maintained | Details |
| Q4 2011 | $1.06 – $1.08 | $1.08 | $240.00M – 246.00M | N/A | = Maintained | Details |
| Q3 2011 | $0.98 – $1.00 | $0.98 | $230.00M – 245.00M | $234.49M | = Maintained | Details |
| Q2 2011 | N/A | N/A | $215.00M – 220.00M | $218.70M | = Maintained | Details |
